1206 PHARMACODYNAMICS OF ORAL TLR-7 AGONIST GS-9620 IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C

E. Lawitz,D. Gruener,T. Marbury,J. Hill,L. Webster,D. Hassman,S. Pflanz,B. Massetto,M. Subramanian,J. McHutchison,I. M. Jacobson,B. Freilich,M. Rodriguez-Torres

Journal of hepatology（2013）

引用 0|浏览30

暂无评分

摘要

Conclusion:Baseline PI-resistance mutations were detected at baseline in 7.8% of the patients.Their role in therapy outcome in vivo is under investigation.These results will be used for the update of the geno2pheno [HCV] tool to improve the prediction of therapy success.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要